logo

For the Inventor, By the Inventor

Tokyo, Japan

Sbi Pharmaceuticals Co., Ltd.


USPTO Granted Patents = 41



Trademarks = 2

Forward Citations = 61

Loading Chart...
Loading Chart...

86 inventors (with patents filed for the assignee):

goldMedal Tohru Tanaka (30 out of 42 patents)

silverMedal Kiwamu Takahashi (17 out of 17 patents)

bronzeMedal Motowo Nakajima (17 out of 17 patents)

4.  Fuminori Abe (11 out of 13 patents)

5.  Masahiro Ishizuka (10 out of 15 patents)

6.  Hidenori Ito (7 out of 14 patents)

7.  Ko Rii (5 out of 6 patents)

8.  Satofumi Kawata (5 out of 5 patents)

9.  Tohru Tanaka (5 out of 18 patents)

10.  Keiji Inoue (4 out of 4 patents)

11.  Takuya Ishii (4 out of 10 patents)

12.  Naomi Haga (4 out of 4 patents)

13.  Katsushi Inoue (3 out of 3 patents)

14.  Takeo Kohda (3 out of 3 patents)

15.  Masayuki Tsuda (2 out of 2 patents)


Core Competencies:
Cancer Therapeutics
Photodynamic Therapy
Immune Checkpoint Inhibitors
Nuclear Magnetic Resonance
Transplant Organ Survival
5-Aminolevulinic Acid
Bladder Cancer Detection
Antimalarial Drugs
Radiation Damage Treatment
Chronic Kidney Disease
Mitochondrial Dysfunction
Allergic Rhinitis

41 patents:

1. 12433857 - Conjugate and cancer therapeutic agent (2025-10-07),
2. 11849922 - Light source device (2023-12-26),
3. 11633505 - Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same (2023-04-25),
4. 11421204 - Method of removing pluripotent cells from culture (2022-08-23),
5. 11266619 - Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor (2022-03-08),
6. 11123320 - Prophylactic or therapeutic agent for hyperaciive bladder (2021-09-21),
7. 10974062 - Photoirradiation substrate (2021-04-13),
8. 10675242 - Aqueous formulation containing 5-aminolevulinic acid or the like (2020-06-09),
9. 10022345 - Agent for preventing and/or treating veisalgia (2018-07-17),
10. 9962350 - Agent for improving normal development rate of fertilized eggs (2018-05-08),
11. 9937138 - Enhancer of survival of transplanted organ (2018-04-10),
12. 9901558 - Enhancer of survival of transplanted organ (2018-02-27),
13. 9895331 - Prophylactic and/or therapeutic agent for radiation damage (2018-02-20),
14. 9772286 - Method for detection of urothelial cancer (2017-09-26),
15. 9757357 - Photodynamic therapy or diagnostic agent, using infrared-spectrum light (2017-09-12),
SBI Pharmaceuticals Co., Ltd. is a leading pharmaceutical company based in Japan. We specialize in the research, development, and manufacture of high-quality pharmaceutical products. With our dedicated team of scientists and state-of-the-art facilities, we strive to improve the health and well-being of people worldwide. Visit our website to learn more about our innovative products and commitment to excellence.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

41 Patents

#792 in Tokyo

#1,897 in Japan

#16,213 in the World

...
Tokyo, Japan

Sbi Pharmaceuticals Co., Ltd.

Forward Citations = 61

86 inventors:

goldMedal Tohru Tanaka (30 out of 42 patents)

silverMedal Kiwamu Takahashi (17 out of 17 patents)

bronzeMedal Motowo Nakajima (17 out of 17 patents)

4.  Fuminori Abe (11 out of 13 patents)

5.  Masahiro Ishizuka (10 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…